Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
03/2004
03/31/2004EP1403247A1 N-Alkanoylphenylalanine derivatives
03/31/2004EP1401918A2 Biodegradable poly(beta-amino esters) and uses thereof
03/31/2004EP1401824A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
03/31/2004EP1401821A1 Novel phenylalkyl diamine and amide analogs
03/31/2004EP1401816A1 Process for the production of the piperidine derivative fexofenadine
03/31/2004EP1401815A1 Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-alpha,alpha-dimethylphenyl acetic acid
03/31/2004EP1401814A1 Derivatives of 3-phenyl-n-(2- (4-benzyl) piperidin-1-yl)-ethyl)-acrylamid with ccr-3 receptor antagonistic activity for use in the treatment of inflammations and allergic conditions
03/31/2004EP1102766B1 Triazolopyridines for the treatment of thrombosis disorders
03/31/2004EP1015421B1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments
03/31/2004EP1003720B1 Aryloxyarylsulfonylamino hydroxamic acid derivatives
03/31/2004CN1486352A Ink-jet ink and recording material
03/31/2004CN1485320A Method for producing high purity antimer of (2s,3s)-1-tert-butoxy carbonyl-3-hydroxy-2-phenyl piperidine
03/31/2004CN1143853C Preparing method for anti-viral compounds
03/31/2004CN1143848C 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists
03/30/2004US6713651 β2-adrenergic receptor agonists
03/30/2004US6713627 For receptor antagonists in treatment of schizolphrenia, anxiety, variant angina, anorexia vervosa, raynaud's phenomenon, intermittent claudication, coronary or peripheral vasospasms, fibromyalgia, cardiac arrhythmia's, and thrombosis
03/30/2004US6713580 Quaternary amino acids on solid supports
03/30/2004US6713492 N-acyloxylated cycloalkyl compounds, composition containing the same and methods of use therefor
03/30/2004US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
03/30/2004US6713479 Piperidine-piperazine ligands for neurotransmitter receptors
03/30/2004US6713467 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer
03/30/2004CA2278687C 5-aroylnaphthalene derivatives
03/30/2004CA2067924C N-alkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
03/25/2004WO2004024991A1 Organic salts and their use as reagents in electrochemical reactions
03/25/2004WO2004024720A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
03/25/2004WO2004024713A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents
03/25/2004WO2004024712A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same
03/25/2004WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
03/25/2004WO2004024690A1 S-(-)-amlodipine nicotinate and process for the preparation thereof
03/25/2004WO2004024689A1 Processes for the preparation of s-(-)-amlodipine
03/25/2004WO2004024687A1 Benzoyl compounds having imino group and herbicides
03/25/2004WO2004024679A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/25/2004WO2004006927A3 Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors
03/25/2004WO2004000808A3 N-substituted piperidine derivatives as serotonin receptor agents
03/25/2004WO2004000218A3 Method for making aryl hydrazines and substituted indoles
03/25/2004WO2003084941A3 Hydroxamic acid derivatives
03/25/2004WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives
03/25/2004US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof
03/25/2004US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics
03/25/2004US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use
03/25/2004US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents
03/25/2004US20040058967 Crystalline organic acid salt of amlodipine
03/25/2004US20040058962 Central nervus system diosrders; muscular disorders; incontinence
03/25/2004US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases
03/25/2004US20040058960 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/25/2004US20040058958 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
03/25/2004US20040058955 Polymorphs of fexofenadine hydrochloride
03/25/2004US20040058954 Antiproliferative agents; anticancer agents
03/25/2004US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
03/25/2004US20040058905 FKBP inhibitors
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004CA2503732A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same
03/25/2004CA2498628A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents
03/25/2004CA2498272A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
03/25/2004CA2497003A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/25/2004CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
03/24/2004EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders
03/24/2004EP1400512A1 Crystalline organic acid salt of amlodipine
03/24/2004EP1400511A1 Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor
03/24/2004EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
03/24/2004EP1399422A2 Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl] -1-hydroxybutyl] -a,a-dimethylbenzene acetic acid and its hydrochloride
03/24/2004EP1399421A1 Substituted imidates as pesticidal agents
03/24/2004EP1399408A1 Method for producing (meth)acrylic acid esters
03/24/2004EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
03/24/2004EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/24/2004EP0986393B1 The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
03/24/2004EP0958281B1 Resolution of ritalinic acid salt
03/24/2004CN1484633A N (phenylsulphonyl) glycine derivatives and their therapentic use
03/24/2004CN1483716A Stibene derivative organic amine salt, its preparation method, use and medicinal composition
03/24/2004CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use
03/24/2004CN1142911C Compounds with growth hormone releasing properties
03/24/2004CN1142910C Amide compounds
03/23/2004US6710204 N-oxyl compound contained in an easily polymerizable material can be sufficiently decreased and loss of easily polymerizable material (acrylic or methacrylic acids or their esters) is little
03/23/2004US6710186 Conformationally-restricted; analogous to poly(proline) ii helical structure
03/23/2004US6710179 Compounds with analgesic effect
03/23/2004US6710060 4-hydroxypiperidine derivatives having antiarrhythmic activity
03/23/2004US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders
03/23/2004US6710043 Possess the potentiation of the cholinergic activity
03/23/2004US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
03/23/2004US6710040 Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
03/23/2004CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them
03/18/2004WO2004022539A1 Naphthyl ether compounds and their use
03/18/2004WO2004022536A1 New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
03/18/2004WO2004022534A1 Arylglycine derivatives for use as glycine transport inhibitors
03/18/2004WO2004022526A1 Cathepsin cysteine protease inhibitors
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction
03/18/2004WO2003094830A3 Novel azacyclic ethynyl derivatives
03/18/2004WO2003079975A3 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
03/18/2004WO2003018535A3 Novel aminobenzoephenones
03/18/2004US20040054187 Therapeutic ureas
03/18/2004US20040054184 Preservative for organs, synthetic blood
03/18/2004US20040053967 3-(3-Amidinophenyl)-5-[({[1-(1-(iminoethyl)-4-piperidyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same
03/18/2004US20040053936 Medicinal composition for oral use
03/18/2004US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto
03/18/2004US20040053917 Reacting cyanophenyl-4-sulfonylchloride with a piperidine-4-oxo in presence of ethylene glycol to form an intermediate, reducing cyano group, followed by amidation, then reacting with an amine to form sulfonamide end
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040052981 Ink jet recording material
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004CA2495939A1 Cathepsin cysteine protease inhibitors